NT 10-Q

NT 10-Q Filing

Company: Protalix BioTherapeutics, Inc.
Filed: May 16, 2001
Period of Report: March 31, 2001
Accession Number: 0000950170-01-500258

View Document ↗ View on SEC.gov ↗